133 related articles for article (PubMed ID: 10830747)
21. Role of Rel/NF-kappaB transcription factors during the outgrowth of the vertebrate limb.
Kanegae Y; Tavares AT; Izpisúa Belmonte JC; Verma IM
Nature; 1998 Apr; 392(6676):611-4. PubMed ID: 9560158
[TBL] [Abstract][Full Text] [Related]
22. Alternative and canonical NF-kB pathways DNA-binding hierarchies networks define Hodgkin lymphoma and Non-Hodgkin diffuse large B Cell lymphoma respectively.
Gamboa-Cedeño AM; Castillo M; Xiao W; Waldmann TA; Ranuncolo SM
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1437-1448. PubMed ID: 30941572
[TBL] [Abstract][Full Text] [Related]
23. The c-Rel transcription factor and B-cell proliferation: a deal with the devil.
Gilmore TD; Kalaitzidis D; Liang MC; Starczynowski DT
Oncogene; 2004 Mar; 23(13):2275-86. PubMed ID: 14755244
[TBL] [Abstract][Full Text] [Related]
24. [Expression of NF-kappa B in human bladder cancer and its clinical significance].
Xie DH; Tang XD; Xia SJ; Tan JM; Wang XH; Cai Y
Ai Zheng; 2002 Jun; 21(6):663-7. PubMed ID: 12452071
[TBL] [Abstract][Full Text] [Related]
25. Molecular cloning and characterization of a novel Rel/NF-kappa B family member displaying structural and functional homology to NF-kappa B p50/p105.
Mercurio F; Didonato J; Rosette C; Karin M
DNA Cell Biol; 1992 Sep; 11(7):523-37. PubMed ID: 1388725
[TBL] [Abstract][Full Text] [Related]
26. Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies.
Fracchiolla NS; Lombardi L; Salina M; Migliazza A; Baldini L; Berti E; Cro L; Polli E; Maiolo AT; Neri A
Oncogene; 1993 Oct; 8(10):2839-45. PubMed ID: 8378093
[TBL] [Abstract][Full Text] [Related]
27. Signaling mediated by the NF-κB sub-units NF-κB1, NF-κB2 and c-Rel differentially regulate Helicobacter felis-induced gastric carcinogenesis in C57BL/6 mice.
Burkitt MD; Williams JM; Duckworth CA; O'Hara A; Hanedi A; Varro A; Caamaño JH; Pritchard DM
Oncogene; 2013 Dec; 32(50):5563-73. PubMed ID: 23975431
[TBL] [Abstract][Full Text] [Related]
28. BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study.
McKeithan TW; Takimoto GS; Ohno H; Bjorling VS; Morgan R; Hecht BK; Dubé I; Sandberg AA; Rowley JD
Genes Chromosomes Cancer; 1997 Sep; 20(1):64-72. PubMed ID: 9290956
[TBL] [Abstract][Full Text] [Related]
29. The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemia.
Chapiro E; Radford-Weiss I; Bastard C; Luquet I; Lefebvre C; Callet-Bauchu E; Leroux D; Talmant P; Mozziconacci MJ; Mugneret F; Struski S; Raynaud S; Andrieux J; Barin C; Jotterand M; Mossafa H; Ramond S; Terré C; Lippert E; Berger F; Felman P; Merle-Béral H; Bernard OA; Davi F; Berger R; Nguyen-Khac F
Leukemia; 2008 Nov; 22(11):2123-7. PubMed ID: 18449207
[No Abstract] [Full Text] [Related]
30. BAFF-R promotes cell proliferation and survival through interaction with IKKbeta and NF-kappaB/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells.
Fu L; Lin-Lee YC; Pham LV; Tamayo AT; Yoshimura LC; Ford RJ
Blood; 2009 May; 113(19):4627-36. PubMed ID: 19258594
[TBL] [Abstract][Full Text] [Related]
31. Molecular profiling of the role of the NF-kappaB family of transcription factors during alloimmunity.
Finn PW; He H; Ma C; Mueller T; Stone JR; Liou HC; Boothby MR; Perkins DL
J Leukoc Biol; 2002 Nov; 72(5):1054-62. PubMed ID: 12429729
[TBL] [Abstract][Full Text] [Related]
32. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
Starczynowski DT; Trautmann H; Pott C; Harder L; Arnold N; Africa JA; Leeman JR; Siebert R; Gilmore TD
Oncogene; 2007 Apr; 26(19):2685-94. PubMed ID: 17072339
[TBL] [Abstract][Full Text] [Related]
33. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
Epinat JC; Kazandjian D; Harkness DD; Petros S; Dave J; White DW; Gilmore TD
Oncogene; 2000 Feb; 19(5):599-607. PubMed ID: 10698504
[TBL] [Abstract][Full Text] [Related]
34. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel.
Gilmore TD; Cormier C; Jean-Jacques J; Gapuzan ME
Oncogene; 2001 Oct; 20(48):7098-103. PubMed ID: 11704834
[TBL] [Abstract][Full Text] [Related]
35. Participation of the E3-ligase TRIM13 in NF-κB p65 activation and NFAT-dependent activation of c-Rel upon T-cell receptor engagement.
Hatchi EM; Poalas K; Cordeiro N; N'Debi M; Gavard J; Bidère N
Int J Biochem Cell Biol; 2014 Sep; 54():217-22. PubMed ID: 25088585
[TBL] [Abstract][Full Text] [Related]
36. The increased transcriptional response and translocation of a Rel/NF-κB homologue in scallop Chlamys farreri during the immune stimulation.
Zhou Z; Wang M; Zhao J; Wang L; Gao Y; Zhang H; Liu R; Song L
Fish Shellfish Immunol; 2013 May; 34(5):1209-15. PubMed ID: 23403154
[TBL] [Abstract][Full Text] [Related]
37. The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression.
Sovak MA; Arsura M; Zanieski G; Kavanagh KT; Sonenshein GE
Cell Growth Differ; 1999 Aug; 10(8):537-44. PubMed ID: 10470853
[TBL] [Abstract][Full Text] [Related]
38. Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection.
Mishra A; Bharti AC; Varghese P; Saluja D; Das BC
Int J Cancer; 2006 Dec; 119(12):2840-50. PubMed ID: 16998793
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile.
Chin M; Herscovitch M; Zhang N; Waxman DJ; Gilmore TD
Oncogene; 2009 May; 28(20):2100-11. PubMed ID: 19377508
[TBL] [Abstract][Full Text] [Related]
40. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis.
Zong WX; Edelstein LC; Chen C; Bash J; Gélinas C
Genes Dev; 1999 Feb; 13(4):382-7. PubMed ID: 10049353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
